Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Feb;9(2):739-46.
doi: 10.1128/mcb.9.2.739-746.1989.

Negative control region at the 5' end of murine leukemia virus long terminal repeats

Affiliations

Negative control region at the 5' end of murine leukemia virus long terminal repeats

J R Flanagan et al. Mol Cell Biol. 1989 Feb.

Abstract

Using in vitro protein binding and in vivo functional studies, we have identified novel regulatory sequences near the 5' end of murine leukemia virus (MuLV) long terminal repeats (LTRs). These sequences are highly conserved in all MuLV LTRs as well as in feline leukemia virus and gibbon ape leukemia virus LTRs. In this upstream conserved region (UCR), gel retardation assays detected two overlapping but distinct binding sites (UCR-U and UCR-L) for nuclear proteins (UCRF-U and UCRF-L). Three lines of evidence suggest a negative regulatory role for the UCR in viral transcription: (i) an inverse correlation was found between MuLV transcripts and nuclear proteins binding the UCR in the spleens of five different mouse strains; (ii) in vivo treatment of NFS mice with lipopolysaccharide resulted in the induction of splenic viral transcripts and the concomitant disappearance of UCR-binding proteins; and (iii) in mouse L cells transfected with an MuLV LTR linked to the chloramphenicol acetyltransferase (CAT) gene, cotransfected UCR oligonucleotides increased CAT expression, presumably by competing for inhibitory trans-acting factors.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Exp Cell Res. 1970 Apr;60(1):61-77 - PubMed
    1. Methods Enzymol. 1983;101:582-98 - PubMed
    1. Virology. 1973 Apr;52(2):456-67 - PubMed
    1. Nature. 1975 Mar 6;254(5495):60-1 - PubMed
    1. J Immunol. 1975 Jul;115(1):317-20 - PubMed